Kavli Oxford Lecture Award 2025 - Daniel M. Skovronsky

The fourth Kavli Oxford Lecture Award will be given by Daniel M. Skovronsky, MD, Phd, Chief Scientific Officer and head of research and development at Ely Lilly and Company.
Hosted by Kavli Oxford’s Founding Director, Professor Dame Carol Robinson, join Dr Skovronsky for a review of the long history behind research into metabolic hormones and how the field is continuing to evolve.

kavlinano.ox.ac.uk/event/kavli-oxford-lecture-award-2025

—-

Dr Skovronsky joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since founding the company in 2004. At Lilly, he has held various leadership roles, including chief medical officer; vice president, tailored therapeutics; vice president, diabetes research; and senior vice president, clinical and product development.

Dr Skovronsky completed his residency training in pathology and fellowship training in neuropathology at the Hospital of the University of Pennsylvania. He received his M.D. from the Perelman School of Medicine, University of Pennsylvania, in 2001, and his Ph.D. in neuroscience from University of Pennsylvania in 2000. Dr Skovronsky earned a Bachelor of Science in molecular biophysics and biochemistry from Yale University in 1994.

—-

The Annual Kavli Lecture will be followed by an open drinks reception, across the road in the Kavli Institute for Nanoscience Discovery (DCHB).
Please note that whilst booking is not required, presentation of University Bodleian cards is essential for entry to both the lecture and the drinks reception; late arrivals to the lecture cannot be accommodated.